These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6106513)

  • 21. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. omega-Amino-2-hydroxy-p-fluorobutyrophenones: synthesis and preliminary pharmacological evaluation.
    Cascio G; Erba R; Manghisi E; Biazzi A; Ferni G; Fregnan GB
    Farmaco Sci; 1980 Jul; 35(7):605-14. PubMed ID: 6108874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological study of the thiophene analogue of taclamine, QM-7184, a new neuroleptic drug with potent alpha-adrenoceptor blocking activity.
    Arribas E; Vega S; Benito C; Fernandez-Tome MP; del Rio J
    Arzneimittelforschung; 1983; 33(10):1417-21. PubMed ID: 6140017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurotensin diminishes grooming and stimulates paper shredding behavior induced by water immersion of rats.
    Van Wimersma Greidanus TJ; Van Zinnicq Bergmann FF; Colbern DL
    Eur J Pharmacol; 1985 Jan; 108(2):201-3. PubMed ID: 4038942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and CNS activity of new 1-alkyl-2-aryl-7-hydroxy-5(1H)oxo-imidazo[1,2-a]pyrymidines.
    Matosiuk D; Tkaczyński T; Stefańczyk J
    Acta Pol Pharm; 1996; 53(3):209-12. PubMed ID: 8960291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of neurotensin on the behavior of rats with damaged serotoninergic neurons under immobilization stress].
    Shugalev NP; Stavrovskaia AV; Iamshchikova NG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2005; 55(5):671-6. PubMed ID: 16316028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
    Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 33. Apomorphine hypothermia: interaction with serotonergic agents.
    Kulkarni SK
    Pol J Pharmacol Pharm; 1980; 32(1):15-20. PubMed ID: 7192860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Adv Biochem Psychopharmacol; 1982; 31():341-6. PubMed ID: 6123224
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolerance to the hypothermic but not to the analgesic effect of [D-Trp11]neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats.
    Dubuc I; Pain C; Suaudeau C; Costentin J
    Peptides; 1994; 15(2):303-7. PubMed ID: 8008636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents.
    Bristow LJ; Flatman KL; Hutson PH; Kulagowski JJ; Leeson PD; Young L; Tricklebank MD
    J Pharmacol Exp Ther; 1996 May; 277(2):578-85. PubMed ID: 8627534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centrally administered neurotensin: activity in the Julou-Courvoisier muscle relaxation test in mice.
    Osbahr AJ; Nemeroff CB; Manberg PJ; Prange AJ
    Eur J Pharmacol; 1979 Mar; 54(3):299-302. PubMed ID: 107032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential neurobehavioral effects of neurotensin and structural analogues.
    Jolicoeur FB; Barbeau A; Rioux F; Quirion R; St-Pierre S
    Peptides; 1981; 2(2):171-5. PubMed ID: 7291042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotensin: an endogenous antipsychotic?
    Kinkead B; Nemeroff CB
    Curr Opin Pharmacol; 2002 Feb; 2(1):99-103. PubMed ID: 11786316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.